| Symbol | MRVI |
|---|---|
| Name | MARAVAI LIFESCIENCES HOLDINGS, INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Address | 10770 WATERIDGE CIRCLE,SUITE 200, SAN DIEGO, California, 92121, United States |
| Telephone | +1 858 546-0004 |
| Fax | — |
| — | |
| Website | https://www.maravai.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001823239 |
| Description | Maravai LifeSciences Holdings Inc is a life sciences company. It provides products to enable the development of drug therapies, diagnostics, novel vaccines and support research on human diseases. The companys segments are Nucleic acid production, Biologics safety testing, and Protein detection. It generates a majority of its revenue from the Nucleic Acid Production that focuses on the manufacturing and sale of nucleic acid products to support the needs of customers research, therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples. Additional info from NASDAQ: |
Director Brust Bernd 🔴 sold 29.2K shares of MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI) at $6.23 Transaction Date: Aug 10, 2026 | Filing ID: 000006
Read moreMaravai LifeSciences To Host Earnings Conference Call on Thursday, August 6, 2026
Read moreMaravai LifeSciences To Host Earnings Conference Call on Thursday, August 6, 2026
Read moreTriLink BioTechnologies® Further Strengthens Global IP Position with Newly Issued Patent in China forCleanCap® Capping Technology
Read moreTriLink BioTechnologies® Further Strengthens Global IP Position with Newly Issued Patent in China for CleanCap® Capping Technology
Read moreNew Form SCHEDULE 13G - MARAVAI LIFESCIENCES HOLDINGS, INC. <b>Filed:</b> 2026-06-29 <b>AccNo:</b> 0001104659-26-078987 <b>Size:</b> 16 KB
Read moreNew Form SCHEDULE 13G - MARAVAI LIFESCIENCES HOLDINGS, INC. <b>Filed:</b> 2026-06-23 <b>AccNo:</b> 0001104659-26-076907 <b>Size:</b> 15 KB
Read moreTriLink Opens GMP Enzyme Manufacturing Facility, Enabling Integrated IVT Supply from R&D to Commercial Scale
Read more